Use of Drug-Coated Balloon to Improve Recanalization of a Coronary Chronic Total Occlusion After Failed Angioplasty

Use of Drug-Coated Balloon to Improve Recanalization of a Coronary Chronic Total Occlusion After Failed Angioplasty: The IMPROVED-RECTO Trial.

Observational retrospective registry to compare effectiveness of paclitaxel-coated vs. non coated balloon angioplasty proximal to a Chronic Total Occlussion (CTO) after failed revascularization. Primary objective is to determine success rate after repeated percutaneous coronary intervention of a CTO 3 to 6 months after paclitaxel-coated balloon angioplasty proximal to the persistent lesion.

Inclusion Criteria:

• Failed recanalization of a CTO in patients with clinical indication for the percutaneous procedure.
• Patient willing to participate in the study providing signed informed consent.
• J-CTO Score ≥2.

Exclusion Criteria:

- Unfeasible recanalization of the CTO according to the interventional cardiologists of the center.